JENNIFER ANDERSON: Open Payments
NPI 1033640925 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 87 payments from 21 companies in 2025. Trend: 2023 $39 · 2024 $758 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $242 |
| AstraZeneca Pharmaceuticals LP | 11 | $228 |
| PFIZER INC. | 9 | $182 |
| Lilly USA, LLC | 9 | $151 |
| ABBVIE INC. | 11 | $151 |
| GlaxoSmithKline, LLC. | 6 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $118 |
| Exact Sciences Corporation | 5 | $104 |
| Dexcom, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
Products named: ELIQUIS, VRAYLAR, Wegovy, BREZTRI, Kerendia, TRELEGY ELLIPTA, Ozempic, REXULTI.
Industry payments across AL — which companies pay providers there.
